alpha-Synuclein filaments bind the transcriptional regulator HMGB-1

Neuroreport. 2004 Dec 22;15(18):2735-9.

Abstract

Abnormal accumulation of alpha-synuclein filaments in Lewy bodies is a neuropathological hallmark of Parkinson's disease and sequestration of cellular protein into these protein aggregates may contribute to the degenerative process. We identified the transcriptional co-factor high mobility group protein 1 (HMGB-1) as a ligand for alpha-synuclein filaments by a filament spin-down technique, mass spectrometric peptide mapping and immunoblotting. HMGB-1 binds preferentially to aggregated alpha-synuclein and is present in alpha-synuclein filament-containing Lewy bodies isolated from brain tissue affected with dementia with Lewy bodies or Parkinson's disease. Our results demonstrate that alpha-synuclein filaments hold the potential for disturbing the cellular gene expression as they can sequester a component involved in cellular transcription regulation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism
  • Brain / pathology
  • HMGB1 Protein / analysis
  • HMGB1 Protein / chemistry
  • HMGB1 Protein / metabolism*
  • HMGB1 Protein / ultrastructure
  • Humans
  • Immunoblotting / methods
  • Immunohistochemistry / methods
  • Iodine Isotopes / metabolism
  • Lewy Bodies / metabolism
  • Lewy Body Disease / metabolism
  • Ligands
  • Microscopy, Immunoelectron / methods
  • Nerve Tissue Proteins / analysis
  • Nerve Tissue Proteins / metabolism*
  • Nerve Tissue Proteins / ultrastructure
  • Neurites / metabolism
  • Neurons / cytology
  • Neurons / metabolism
  • Parkinson Disease / metabolism
  • Peptide Mapping / methods
  • Protein Binding
  • Rats
  • Recombinant Proteins / metabolism
  • Synucleins
  • alpha-Synuclein

Substances

  • HMGB1 Protein
  • Iodine Isotopes
  • Ligands
  • Nerve Tissue Proteins
  • Recombinant Proteins
  • SNCA protein, human
  • Snca protein, rat
  • Synucleins
  • alpha-Synuclein